BNT162b2 COVID-19 vaccine safe and efficacious in young children
1. A three-dose series of BNT162b2 was efficacious in eliciting an immune response and protecting children between six months and ...
1. A three-dose series of BNT162b2 was efficacious in eliciting an immune response and protecting children between six months and ...
1. A single dose of the respiratory syncytial virus (RSV) prefusion F protein vaccine had an acceptable safety profile in ...
1. In this randomized control trial, pegylated interferon lambda reduced the risk of coronavirus disease 2019 (COVID-19)-related hospitalization as compared ...
1. In this retrospective cohort study, maternal vaccination with an mRNA COVID-19 vaccine series during pregnancy was highly effective against ...
1. VV116 is noninferior compared to nirmatrelvir-ritonavir for achieving sustained recovery in mild-to-moderate coronavirus disease 2019 (COVID-19) cases. 2. Participants ...
1. This stochastic dynamic model demonstrated that mpox outbreaks in the United States can be controlled on college campuses with ...
1. In this retrospective cohort study, treatment with nirmatrelvir plus ritonavir was associated with a reduced risk of hospitalization within ...
1. The omicron BA.1-adapted BNT162b2 vaccine candidates elicited significant neutralizing antibodies against the omicron strains as well as the ancestral ...
1. In this trial for the safety of vaccines used to prevent Zaire Ebola virus disease (EVD), no concerns were ...
1. A 24-week regimen of bedaquiline, pretomanid, linezolid, and moxifloxacin (BPaLM) resulted in lower mortality, treatment failure, and discontinuation compared ...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.